Interest of the Reborn® Doll as a TO in the Care of Residents With Alzheimer's Disease or a Related Disorder

Last updated: December 13, 2024
Sponsor: University Hospital, Clermont-Ferrand
Overall Status: Completed

Phase

N/A

Condition

N/A

Treatment

Reborn doll (Therapeutic object - OT)

Clinical Study ID

NCT06396377
RBHP 2023 MARTIN
2023-A00383-42
  • Ages > 65
  • All Genders

Study Summary

The primary objective of this study is to evaluate the benefits of the Reborn®doll as an OT for the care of residents with Alzheimer's disease or related disorders, by assessing the frequency of resident agitation.

The secondary objectives are to study the frequency of treatments, evaluate the average time of exposure to the Reborn® doll, study the behavior of the residents, study the interest of this therapeutic workshop, thanks to an evaluation grid and finally study the repercussions of this OT on the nursing staff.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Resident aged 65 and over

  • Moderate to severe cognitive impairment diagnosed using the NPI-ES scale

  • Behavioral disorders (agitation, aggression, anxiety, apathy) assessed using theNPI-ES scale

  • Covered by a social security plan

  • Written consent of representative (tutor/ curator/trusted person)

Exclusion

Exclusion Criteria:

  • Resident or representative refusing to participate

  • Resident under judicial protection

Study Design

Total Participants: 24
Treatment Group(s): 1
Primary Treatment: Reborn doll (Therapeutic object - OT)
Phase:
Study Start date:
September 16, 2024
Estimated Completion Date:
December 13, 2024

Study Description

Dementia affects 50 million people worldwide, and this number is set to continue rising as the population ages. Indeed, the World Health Organization (WHO) expects this number to reach 82 million by 2030. At present, there is no cure for dementia. In order to limit the need for drug treatments for dementia-related symptoms (agitation, aggression), non-drug treatments can be used to improve residents' lives and soothe them. In the late 1960s, researchers turned their attention to non-medication therapies (snozelen concept, animal mediation, calinotherapy, Tovertafel, Carpe Diem, doll'therapy).

This doll is used by caregivers to calm anxiety attacks, aggression or apathy in residents with MND. The doll helps to calm the elderly by focusing them on an object. Several studies have shown that residents are calmed and feel valued by taking care of the doll. This also helps to avoid physical or chemical restraints, as well as the use of drug therapies in cases of agitation. Reborn® dolls are an evolution of Doll'therappy.

Connect with a study center

  • CHU de Clermont-Ferrand

    Clermont-Ferrand, 63000
    France

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.